Founded
31 Dec 1993
Address
Three Arch Partners
3200 Alpine Road
Portola Valley, CA 94028
United States
Phone
Website
Industry
Business classification
VCID: 32222
Profile
Founders
Corporate information
Registration country
Registration country
Investment activity status
Not investing
Company type
Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors.Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Three Arch Partners IV | Venture | 2004 |
| Three Arch Capital | 2000 |
|
| Three Arch Partners III | Venture | 1999 |
| Three Arch Partners II | Venture | 1997 |
| Three Arch Partners I | Venture | 1994 |
Investments
Investment preferences
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Nevro Corp Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. |
United States | 1 Aug 2008 1 Jul 2011 |
N/A |
|
|
|
Neuronetics Inc |
United States | 1 May 2011 1 Oct 2009 |
Series E |
|
|
|
Baxano Inc A medical device company focused on developing minimally invasive tools to restore spine function and preserve healthy tissue. |
United States | 22 Jun 2010 | Series C Active |
|
|
|
Hemosphere Inc Developed a vascular access product that has the potential to significantly reduce the risk of bacteremia |
United States | 1 Apr 2010 | Series A Active |
|
|
|
Calibra Medical Inc A medical device company developing a unique, wearable three-day insulin patch. |
United States | 1 Aug 2008 1 Nov 2009 |
N/A Active |
|
|
|
iScience Interventional Inc Leading the discovery and development of the product platforms used in Interventional Ophthalmology |
United States | 1 May 2009 | Series F |
|
|
|
Visiogen Inc A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. |
United States | 1 May 2009 | Series D Initial investment. Round participant. Active |
|
|
|
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. |
United States | 1 Nov 2008 | Series A |
|
|
|
Cardiac Concepts Inc Now known as Respicardia Inc |
United States | 1 Oct 2008 | Series B |
|
|
|
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. |
United States | 1 Sep 2008 | Series A Initial investment. Round participant. Active |
|
|
|
Concert Pharmaceuticals Inc A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. |
United States | 1 Apr 2008 30 Nov 2006 |
Series C Initial investment. Round participant. Active |
|
|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Jan 2008 | Series B |
|
|
|
NeuroVista Corp |
United States | 1 May 2007 | Series B |
|
|
|
Reliant Technologies Inc A medical device company that has developed and manufactured laser technology that stimulated the body to replace aged, photo-damaged skin. |
United States | 1 Apr 2007 | Series E |
|
|
|
Calistoga Pharmaceuticals Inc Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. |
United States | 5 Mar 2007 | Series A Active |
|
|
|
LipoScience Inc Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. |
1 Aug 2006 | Series F Active |